HIV-1 integrase strand transfer inhibitors stabilize an integrase-single blunt-ended DNA complex

Journal of Molecular Biology

Volumn 410, Issue 5, 2011, Pages 831-846

  Bera, Sibes ^a   Pandey, Krishan K ^a   Vora, Ajaykumar C ^a   Grandgenett, Duane P ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1; integrase; integrase single DNA complex; slow binding inhibitor mechanism

Indexed keywords

DEOXYRIBONUCLEASE I; ELVITEGRAVIR; INTEGRASE; INTEGRASE INHIBITOR; L 731 988; L 841 411; L 870 810; L 870 812; MK 2048; RALTEGRAVIR; RDS 1997; RDS 2197; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; DNA PROTEIN COMPLEX; DRUG DNA BINDING; ENZYME INHIBITION; LONG TERMINAL REPEAT; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79960352459     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.01.043     Document Type: Article

References (48)

1. Chen H.; Wei S.Q.; and Engelman A. Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome J. Biol. Chem. 274 1999 17358 17364
2. Chen H.; and Engelman A. Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA (Pubitemid 32911238)
3. Farnet C.M.; and Haseltine W.A. Integration of human immunodeficiency virus type 1 DNA in vitro Proc. Natl Acad. Sci. USA 87 1990 4164 4168
4. Craigie R. Retroviral DNA integration N.L. Craig, R. Craigie, M. Gellert, A.M. Lambowitz, Mobile DNA II 2002 ASM Press Washington, DC 613 630
5. Hazuda D.J.; Felock P.; Witmer M.; Wolfe A.; Stillmock K.; and Grobler J.A. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells Science 287 2000 646 650 (Pubitemid 30070911)
6. Pommier Y.; Johnson A.A.; and Marchand C. Integrase inhibitors to treat HIV/AIDS Nat. Rev. Drug Discov. 4 2005 236 248 (Pubitemid 40372557)
7. Steigbigel R.T.; Cooper D.A.; Kumar P.N.; Eron J.E.; Schechter M.; and Markowitz M. Raltegravir with optimized background therapy for resistant HIV-1 infection N. Engl. J. Med. 359 2008 339 354
8. Lennox J.L.; DeJesus E.; Lazzarin A.; Pollard R.B.; Madruga J.V.; and Berger D.S. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial Lancet 374 2009 796 806
9. Sinha S.; Pursley M.H.; and Grandgenett D.P. Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors J. Virol. 76 2002 3105 3113 (Pubitemid 34224512)
10. Sinha S.; and Grandgenett D. Recombinant HIV-1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegraton complexes from virus-infected cells J. Virol. 79 2005 8208 8216 (Pubitemid 40853524)
11. Li M.; and Craigie R. Processing of viral DNA ends channels the HIV-1 integration reaction to concerted integration J. Biol. Chem. 280 2005 29334 29339 (Pubitemid 41161388)
12. Goodarzi G.; Im G.J.; Brackmann K.; and Grandgenett D. Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase J. Virol. 69 1995 6090 6097
13. Valkov E.; Gupta S.S.; Hare S.; Helander A.; Roversi P.; McClure M.; and Cherepanov P. Functional and structural characterization of the integrase from the prototype foamy virus Nucleic Acids Res. 37 2009 243 255
14. Pandey K.K.; Bera S.; Zahm J.; Vora A.; Stillmock K.; Hazuda D.; and Grandgenett D.P. Inhibition of human immunodeficiency virus type-1 concerted integration by strand transfer inhibitors which recognize a transient structural intermediate J. Virol. 81 2007 12189 12199 (Pubitemid 350085834)
15. Zahm J.A.; Bera S.; Pandey K.K.; Vora A.; Stillmock K.; Hazuda D.; and Grandgenett D.P. Mechanisms of human immunodeficiency virus type 1 concerted integration related to strand transfer inhibition and drug resistance Antimicrob. Agents Chemother. 52 2008 3358 3368
16. Li M.; Mizuuchi M.; Burke T.R. Jr, and Craigie R. Retroviral DNA integration: reaction pathway and critical intermediates EMBO J. 25 2006 1295 1304
17. Bera S.; Pandey K.K.; Vora A.C.; and Grandgenett D.P. Molecular interactions between HIV-1 integrase and the two viral DNA ends within the synaptic complex that mediates concerted integration J. Mol. Biol. 389 2009 183 198
18. Li M.; and Craigie R. Nucleoprotein complex intermediates in HIV-1 integration Methods 47 2009 237 242
19. Faure A.; Calmels C.; Desjobert C.; Castroviejo M.; Caumont-Sarcos A.; and Tarrago-Litvak L. HIV-1 integrase crosslinked oligomers are active in vitro Nucleic Acids Res. 33 2005 977 986 (Pubitemid 41430518)
20. Hare S.; Gupta S.S.; Valkov E.; Engelman A.; and Cherepanov P. Retroviral intasome assembly and inhibition of DNA strand transfer Nature 464 2010 232 236
21. Pandey K.K.; Bera S.; Vora A.C.; and Grandgenett D.P. Physical trapping of HIV-1 synaptic complex by different structural classes of integrase strand transfer inhibitors Biochemistry 49 2010 8367 8376
22. Hare S.; Vos A.M.; Clayton R.F.; Thuring J.W.; Cummings M.D.; and Cherepanov P. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance Proc. Natl Acad. Sci. USA 107 2010 20057 20062
23. Krishnan L.; Li X.; Naraharisetty H.L.; Hare S.; Cherepanov P.; and Engelman A. Structure-based modeling of the functional HIV-1 intasome and its inhibition Proc. Natl Acad. Sci. USA 107 2010 15910 15915
24. Kotova S.; Li M.; Dimitriadis E.K.; and Craigie R. Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy J. Mol. Biol. 399 2010 491 500
25. Alian A.; Griner S.L.; Chiang V.; Tsiang M.; Jones G.; and Birkus G. Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs Proc. Natl Acad. Sci. USA 106 2009 8192 8197
26. Langley D.; Samanta H.K.; Lin Z.; Walker M.A.; Krystal M.R.; and Dicker I.B. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors Biochemistry 47 2008 13481 13488
27. Garvey E.P.; Schwartz B.; Gartland M.J.; Lang S.; Halsey W.; and Sathe G. Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutant Biochemistry 48 2009 1644 1653
28. Summa V.; Petrocchi A.; Bonelli F.; Crescenzi B.; Donghi M.; and Ferrara M. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection J. Med. Chem. 51 2008 5843 5855
29. Vacca J.; Wai J.; Fisher T.; Embrey M.; Hazuda D.; and Miller M. Discovery of MK-2048-subtle changes confer unique resistance properties to a series of tricyclic hydroxypyrrole integrase strand transfer inhibitors 4th International AIDS Society (IAS) Conference, July 22-25, 2007, Sydney, Australia 2007
30. Hazuda D.J.; Anthony N.J.; Gomez R.P.; Jolly S.M.; Wai J.S.; and Zhuang L. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase Proc. Natl Acad. Sci. USA 101 2004 11233 11238 (Pubitemid 39038330)
31. Malet I.; Delelis O.; Valantin M.A.; Montes B.; Soulie C.; and Wirden M. Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro Antimicrob. Agents Chemother. 52 2008 1351 1358 (Pubitemid 351521998)
32. Fransen S.; Gupta S.; Danovich R.; Hazuda D.; Miller M.; and Witmer M. Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways J. Virol. 83 2009 11440 11446
33. Espeseth A.S.; Felock P.; Wolfe A.; Witmer M.; Grobler J.; and Anthony N. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase Proc. Natl Acad. Sci. USA 97 2000 11244 11249
34. Grobler J.A.; Stillmock K.; Hu B.; Witmer M.; Felock P.; and Espeseth A.S. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes Proc. Natl Acad. Sci. USA 99 2002 6661 6666 (Pubitemid 34526189)
35. Pandey K.K.; Sinha S.; and Grandgenett D.P. Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration J. Virol. 81 2007 3969 3979 (Pubitemid 46586892)
36. Metifiot M.; Maddali K.; Naumova A.; Zhang X.; Marchand C.; and Pommier Y. Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir Biochemistry 49 2010 3715 3722
37. Marinello J.; Marchand C.; Mott B.T.; Bain A.; Thomas C.J.; and Pommier Y. Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants Biochemistry 47 2008 9345 9354
38. Ceccherini-Silberstein F.; Malet I.; D'Arrigo R.; Antinori A.; Marcelin A.G.; and Perno C.F. Characterization and structural analysis of HIV-1 integrase conservation AIDS Rev. 11 2009 17 29
39. Grobler J.; McKemma P.M.; Ly S.; Stillmock K.A.; Bahnck C.M.; and Danovich R.M. HIV integrase inhibitor dissociation rates correlate with efficacy in vitro Antiviral Ther. 14 2009 A27
40. Hightower K.; Wang R.; and Underwood M.R. S/GSK1349572 demonstrates significantly slower dissociation rates than raltegravir when comparing wild type and raltegravir resistant integrase proteins International HIV & Hepatitis Virus Drug Resistance Workshop, Croatia 2010
41. Bera S.; Vora A.C.; Chiu R.; Heyduk T.; and Grandgenett D.P. Synaptic complex formation of two retrovirus DNA attachment sites by integrase: a fluorescence energy transfer study Biochemistry 44 2005 15106 15114 (Pubitemid 41681446)
42. Oh J.; McWilliams M.J.; Julias J.G.; and Hughes S.H. Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo J. Virol. 82 2008 719 727
43. Miller M.D.; Farnet C.M.; and Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition J. Virol. 71 1997 5382 5390 (Pubitemid 27258214)
44. Chen X.; Tsiang M.; Yu F.; Hung M.; Jones G.S.; and Zeynalzadegan A. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors J. Mol. Biol. 380 2008 504 519 (Pubitemid 351815132)
45. Scottoline B.P.; Chow S.; Ellison V.; and Brown P.O. Disruption of the terminal base pairs of retroviral DNA during integration Genes Dev. 11 1997 371 382 (Pubitemid 27079914)
46. Delelis O.; Malet I.; Na L.; Tchertanov L.; Calvez V.; and Marcelin A.G. The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation Nucleic Acids Res. 37 2009 1193 1201
47. Maertens G.N.; Hare S.; and Cherepanov P. The mechanism of retroviral integration from X-ray structures of its key intermediates Nature 468 2010 326 329
48. Grandgenett D.P.; Bera S.; Pandey K.K.; Vora A.C.; Zahm J.; and Sinha S. Biochemical and biophysical analyses of concerted (U5/U3) integration Methods 47 2009 229 236